Jeremy B.

Jeremy B. is an experienced professional in marketing and commercial operations within the biopharmaceutical industry. Currently serving as the Associate Director of Marketing Operations at Biogen since February 2025, Jeremy leads strategy for the Neuro/Psych Franchise. Prior experience includes roles at bluebird bio, where contributions included announcing FDA approvals for significant therapies such as LYFGENIA™ and SKYSONA®, as well as serving as Associate Director and Senior Manager for Commercial Operations. At Acadia Pharmaceuticals Inc., Jeremy held the position of Manager in Marketing Operations, and previous experience at Allergan involved roles from Supervisor of Multichannel Marketing to Promotional Review Specialist, contributing to key acquisitions in the healthcare sector. Early career experience includes serving as Editor in Regulatory Affairs at Bristol Myers Squibb, where involvement led to the accelerated approval of Opdivo.